Navigation Links
Rigel Announces Pricing of Public Offering of Common Stock
Date:5/26/2011

).

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Rigel Pharmaceuticals, Inc.
Rigel, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as for muscle disorders.

Forward-Looking Information is Subject to Risk and Uncertainty

Certain of the statements made in this press release are forward looking, such as those, among others, relating to Rigel's expectations regarding the completion, timing and size of the public offering and the amount of gross proceeds to be received. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties related to market and other conditions, the satisfaction of customary closing conditions related to the public offering and the impact of general economic, industry or political conditions in the United States or internationally. There can be no assurance that Rigel will be able to complete the public offering at the anticipated size or on the anticipated terms, or at all. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release.  Additional risks and uncertainties relating to the offering, Rigel and its business can be found under the heading "Risk Factors" in Rigel's Quarterly Report on Form 10-Q filed with the SEC on May 3, 2011 and other filings with the SEC, in the preliminary prospectus supplement related to the o
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rigel Announces Proposed Public Offering of Common Stock
2. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
3. Rigel Announces First Quarter Financial Results
4. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
5. Rigel to Present at Three Upcoming Investor Conferences
6. Rigel Announces Participation at Two Investor Conferences
7. Rigel to Present at JP Morgan Healthcare Conference
8. Rigel Announces Third Quarter 2009 Financial Results
9. Rigel Announces Presentations at Two Investor Conferences
10. Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
11. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014  Aethlon Medical, Inc. ... definitive agreement to raise approximately $3.3 million at a ... made by one institutional healthcare focused investor. Each unit consists ... a common share purchase warrant. Each whole warrant entitles ... price of $0.30 for a period of five years ...
(Date:11/26/2014)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... of Regulus, will present a company overview at the ... the New York Palace Hotel on Wednesday, December 3, ... webcast at the time of the presentation and can ...
(Date:11/26/2014)... -- BioScrip ® , Inc. (NASDAQ: BIOS ) announced today ... will present at the Bank of America Merrill Lynch 2014 Leveraged ... , , , Wednesday, December 3, 2014 , , , ... , , Location: , , , Boca Raton Resort and Club, ... BioScrip, Inc. is a leading national provider of ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3
... -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: ... in the development, manufacturing, and marketing of branded and ... Mr. Hong Zhao, a highly regarded executive in the ... sales and marketing, effective February 12, 2011. ...
... Calif., Feb. 10, 2011 Renaissance Surgical Arts at Newport ... center in the Western United States to offer intraoperative radiotherapy ... in the TARGIT-A multicenter human clinical trial that demonstrated IORT ... with early breast cancer. IORT has the ...
Cached Medicine Technology:Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing 2Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer 2Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer 3
(Date:11/27/2014)... Ethane Web Technologies, which is an ... reputation management service. , The company has designed ... world of internet marketing and algorithms of major search ... Web Technologies does not work with the same strategy ... to reach a conclusion what will work for the ...
(Date:11/27/2014)... 2014 VeloReality Inc. President Gary ... Life Videos (RLVs) of world-famous velo courses for the company's ... as other popular indoor velo trainers. Two dozen additional Real ... the end of November -- in time for the ... of rides in the VeloReality collection to over sixty. , ...
(Date:11/27/2014)... November 27, 2014 Serious Buyer, Andrew ... 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum concert posters. Between ... played at the University of Alabama. Jimi Hendrix started ... Hawley, “It started with Gary Weinberger who was a ... University Programs Council. The council was responsible for bringing ...
(Date:11/26/2014)... CA (PRWEB) November 26, 2014 Dr. ... treat themselves this holiday season! With Parsa Mohebi Hair ... 10% off of their next FUE procedure, making it ... , FUE—which stands for “Follicular Unit Extraction”—is an advanced ... over traditional “strip” Follicular Unit Transplantation (FUT). FUE, unlike ...
(Date:11/26/2014)... 27, 2014 Sweetdressy.com, the well-known wedding ... newest selection of cheap prom dresses for ladies worldwide. ... The prom dresses from Sweetdressy.com are very popular in ... the website of Sweetdressy.com now. , Sweetdressy.com believes ... that offering the best items and best services. The ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2Health News:Cheap Prom Dresses For Ladies Introduced At SweetDressy.com 2
... May 8 (HealthDay News) -- People at risk for celiac ... they show no symptoms, a new study suggests. Celiac ... small intestine when the person consumes gluten, a protein found ... with the disease has grown rapidly in recent decades, but, ...
... , MONDAY, May 9 (HealthDay News) -- Some ... emotional reactions to everyday situations, a combination that appears ... a Massachusetts General Hospital study that included 83 participants ... deficient emotional self-regulation (DESR), 33 with neither condition -- ...
... of U.S. children taken to hospital emergency departments (EDs) for ... ease worried parents, concerns. Yet true traumatic brain injury is ... minor blunt head trauma, led by Children,s Hospital Boston and ... reduce the use of head CT by as much as ...
... UK,s betting shops are attracting a new type of ... terms of problem gambling, argues initial research findings funded ... Betting shops today are virtually unrecognisable compared to the ... Act. "Under the Act, the newly licensed betting offices ...
... -- (May 9, 2011) In the wild, mammals survive ... shadowy bushes. That ability translates to the human ... in an image of our messy and stuffed suitcases. We ... our car keys on that cluttered shelf next to the ...
... patient without common symptoms of celiac disease is accurately ... study from the Beth Israel Deaconess Medical Center in ... divided the cases of nearly 800 adult patients with ... per capita earnings. Some patients had complained of acute ...
Cached Medicine News:Health News:More People May Benefit From Going Gluten-Free 2Health News:ADHD With Poor Emotional Control Seems to Run in Families 2Health News:Large study finds CT scans are frequently unnecessary after head injury in children 2Health News:Large study finds CT scans are frequently unnecessary after head injury in children 3Health News:50 years on, UK betting shops lure new breed of punters 2Health News:The brain performs visual search near optimally 2
... Korchek Technologies CareChek ... employs barcode technology, Windows ... with integrated scanners (to ... at the bedside) and ...
... Korchek Technologies CareChek Rx ... barcode technology, Windows CE ... integrated scanners (to perform ... the bedside) and an ...
... care management tools that support the nursing ... vital signs and I&O information at the ... on-line flow sheets. This design supports compliance ... the hall, or at the nursing station, ...
For superior bar code scanning performance with maximum user comfort at a highly attractive price, the LS 4000i Scanner Series from Symbol Technologies establishes an award-winning standard of excell...
Medicine Products: